ArticleNeuromolecular medicine2015

NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome.

Robert M J Deacon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.